The cardiorenal anaemia syndrome in systolic heart failure: Prevalence, clinical correlates, and long-term survival

European Journal of Heart Failure

Volumn 13, Issue 1, 2011, Pages 61-67

  Scrutinio, Domenico ^a   Passantino, Andrea ^a   Santoro, Daniela ^a   Catanzaro, Raffaella ^a  

^a NATIONAL CANCER INSTITUTE GIOVANNI PAOLO II   (Italy)

Author keywords

Anaemia; Heart failure; Prognosis; Renal dysfunction

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; HEMOGLOBIN;

ADULT; ANEMIA; ARTICLE; BODY MASS; CORRELATION ANALYSIS; DIABETES MELLITUS; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEMOGLOBIN BLOOD LEVEL; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; SURVIVAL; SYNDROME; SYSTOLIC DYSFUNCTION; SYSTOLIC HEART FAILURE;

AGED; CONFIDENCE INTERVALS; DISEASE PROGRESSION; FEMALE; GLOMERULAR FILTRATION RATE; HEART FAILURE, SYSTOLIC; HUMANS; ITALY; KAPLAN-MEIER ESTIMATE; KIDNEY DISEASES; LOGISTIC MODELS; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PREVALENCE; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; TIME FACTORS;

EID: 78650348663     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfq167     Document Type: Article

References (30)

1. Silverberg DS, Wexler D, Iaina A, Steinbrich S, Wollman Y, Schwartz D. Anemia, chronic renal disease and congestive heart failure-the cardio renal anemia syndrome: the need for cooperation between cardiologists and nephrologists. Int Urol Nephrol 2006;38:295-310.
2. Bongartz LG, Cramer MJ, Doevendans PA, Joles JA, Braam B. The severe cardior-enal syndrome: 'Guyton revisited'. Eur Heart J 2005;26:11-17.
3. van der Meer P, van Veldhuisen DJ. Anaemia and renal dysfunction in chronic heart failure. Heart 2009;95:1808-1812.
4. Go AS, Yang J, Ackerson LM, Lepper K, Robbins S, Massie BM, Michael G, Shlipak MG. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure. The anemia in chronic heart failure: outcomes and resource utilization (ANCHOR) study. Circulation 2006;113:2713-2723.
5. Groenveld HF, Januzzi JL, Damman K, van Wijngaarden J, Hillege HL, van Veldhuisen DJ, van der Meer P. Anemia and mortality in heart failure patients. J Am Coll Cardiol 2008;52:818-827.
6. Ronco C, Haapio M, House AA, Anakevar N, Bellomo R. Cardiorenal syndrome. J Am Coll Cardiol 2008;52:1527-1539.
7. Ansalem Y, Garty M, Schwartz R, Sandach A, Behar S, Caspi A, Gottlieb S, Ezra D, Lewis BS, Leor J. Prevalence and significance of unrecognized renal insufficiency in patients with heart failure. Eur Heart J 2008;29:1029-1036.
8. Tang WHW, Tong W, Anil J, Gary FS, Martin HC, James YB. Evaluation and long-term prognosis of new-onset, transient, and persistent anemia in ambulatory patients with chronic heart failure. J Am Coll Cardiol 2008;51:569-576.
9. Damman K, Jaarsma DK, Voors AA, Navis G, Hillege HL, van Veldhuisen DJ; COACH Investigators. Both in- and out-hospital worsening of renal function predict outcome in patients with heart failure: results from the Coordinating Study Evaluating Outcome of Advising and Counseling in Heart Failure (COACH). Eur J Heart Fail 2009;11:847-854.
10. Nohria A, Hasselblad V, Stebbins A, Pauly DF, Fonarow GC, Shah M, Yancy CW, Califf RM, Stevenson LW, Hill JA. Cardiorenal interaction. Insights from the ESCAPE trial. J Am Coll of Cardiol 2008;51:1268-1274.
11. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creati-nine. Nephron 1976;16:31-41.
12. Manjunath G, Sarnak MJ, Levey AS. Prediction equations to estimate glomerular filtration rate: an update. Curr Opin Nephrol Hypertens 2001;10:785-792.
13. Lamb EJ, Tomson CRV, Roderick PJ. Estimating kidney function in adults using formulae. Ann Clin Biochem 2005;42:321-345.
14. KDOQI. II. Clinical practice guidelines and clinical practice recommendations for anemia inchronic kidney disease inadults. AmJKidney Dis 2006;47(Suppl. 3):S16-S85.
15. Pocock SJ, Wang D, Pfeffer MA, Yusuf S, McMurray JJV, Swedberg KB, Ostergren J, Michelson EL, Pieper KS, Granger CB. Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J 2006;27:65-75.
16. Jackson CE, Solomon SD, Gerstein HC, Zetterstrand S, Olofsson B, Michelson EL, Granger CB, Swedberg K, Pfeffer MA, Yusuf S, McMurray JJ; CHARM Investigators and Committees. Albuminuria in chronic heart failure: prevalence and prognostic importance. Lancet 2009;374:543-550.
17. Sarafidis PA, Bakris GL. Renin-angiotensin blockade and kidney disease. Lancet 2008;372:511-512.
18. Silverberg DS, Wexler D, Iaina A, Schwartz D. The correction of anemia in patients with the combination of chronic kidney disease and congestive heart failure may prevent progression of both conditions. Clin Exp Nephrol 2009;13: 101-106.
19. Silverberg DS, Wexler D, Iaina A, Schwartz D. The role of correction of anemia in patients with congestive heart failure: a short review. Eur J Heart Fail 2008;10: 819-823.
20. Van der Meer P, Groenveld HF, Januzzi JL Jr, van Veldhuisen DJ. Erythropoietin treatment in patients with chronic heart failure: a meta-analysis Heart 2009;95: 1309-1314.
21. Jin B, Luo X, Lin H, Li J, Shi H. A meta-analysis of erythropoiesis- stimulating agents in anaemic patients with chronic heart failure. Eur J Heart Fail 2010;12: 249-253.
22. McMurray JJV, Anand IS, Diaz R, Maggioni AP, O'Connor C, Pfeffer MA, Polu KR, Solomon SD, Sun Y, Swedberg K, Tendera M, van Veldhuisen DJ, Wasserman SM, Young JB, on behalf of the RED-HF Committees and Investigators. Design of the Reduction of Events with Darbepoetin alfa in heart failure (RED-HF): a phase III, anaemia correction, morbidity-mortality trial. Eur J Heart Fail 2009;11: 795-801.
23. Anker SD, Colet JC, Filippatos G, Willenheimer R, Dickstein K, Drexler H, Lüscher TF, Bart B, Banasiak W, Niegowska J, Kiran BA, Mori C, von Eisenheart Rothe B, Pocock SJ, Poole-Wilson PA, Ponikowski P, on behalf of the FAIR-HF. Committees and Investigators. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 2009;361:2436-2448.
24. Fishbane S, Miyawaki N. Anemia treatment in chronic kidney disease accompanied by diabetes mellitus or congestive heart failure. Kidney Int 2010;77:175-177.
25. Herzog CA, Muster HA, Li S, Collins AJ. Impact of congestive heart failure, chronic kidney disease, and anemia on survival in the Medicare population. J Card Fail 2004;10:467-472.
26. Al-Ahmad A Rand WM Manjunath G Konstam MA Salem DN Levey AS Sarnak MJ. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol 2001;38:955-962.
27. Hachamovitch R Di Carli MF. Methods and limitations of assessing new noninva-sive tests. Part II: Outcomes-based validation and reliability assessment of non-invasive testing. Circulation 2008;117;2793-2801.
28. von Elm E Altman DG Egger M Pocock SJ Gøtzsche PC Vandenbroucke JP for the STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Int Med 2007;147:573-577. (Pubitemid 351664504)
29. Lauer MS Blackstone EH Young JB Topol EJ. Cause of death in clinical research. J Am Coll Cardiol 1999;34:618-620.
30. Schroten NF van der Putten K Rutten FH Diepenbroek A Mosterd A Gaillard CAJM. High cumulative incidence of cancer in patients with cardio-renal-anaemia syndrome. Eur J Heart Fail 2010;12:855-860.